Submit Deal

SPRINGWORKS THERAPEUTICS

HQ - Stamford

Summary

SpringWorks is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 2.55 B

Avg. Deal Size£ 2.55 B

Market Context

Senior Management

Sort

Target: SPRINGWORKS THERAPEUTICS

Bidder: MERCK KGAA

8 Service Providers

42 Dealmakers

£ 2.55 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy